Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study
- 505 Downloads
Primary headaches (migraines and tension-types headaches) are very common in school-aged children. Ginkgolide B, a herbal constituent extract from Ginkgo biloba tree leaves, was considered as a promising pharmacological aid for the treatment of migraine in adult patients because of its modulation of the glutamatergic transmission in the CNS and on antiplatelet activating factor (PAF). The aim of study is to verify the effectiveness and safety of association of Ginkgolide B/Coenzyme Q10/Riboflavin/Magnesium complex for brief prophylaxis in a population of school-aged children with migraine. In our sample after 3 months of treatment with association of Ginkgolide B/CoenzymeQ10/Riboflavin/Magnesium complex, the mean frequency per month of migraine was significantly decreased (9.71 ± 4.33 vs. 4.53 ± 3.96 attacks; p < 0.001). Our findings suggest that in childhood headache management, the use of alternative treatments must be considered not to evoke a placebo effect, but as soft therapy without adverse reactions.
KeywordsChildhood migraine Vitaminic complexes Natural therapy Brief prophylaxis
Conflict of interest
None of the authors have received any financial support.
- 1.Anttila P, Metshäonkala L, Sillanpää M (2004) Secular long trends in headache occurrence in schoolchildren. J Headache Pain 5:65Google Scholar
- 13.Menke T (2008) Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status. Georgian Med News (156):24–32Google Scholar
- 23.Akisu M, Kultursay N, Coker I, Huseyinov A (1998) Platelet activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo Biloba extracts reduce PAF concentration in the brain. Biol Neonate 74(6):439–444Google Scholar
- 25.Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, edn 2. Cephalalgia 24(Suppl 1):1–15Google Scholar